Pro Medicus Limited (ASX:PME) announces a share repurchase program. Under the program, the company will repurchase up to 10,435,575 shares, representing 10% of its issued share capital. The purpose of the program is capital management.

The program will expire on March 31, 2023. As of April 1, 2022, the company has 104,355,753 shares in issue.